In this respect, the expression of multidrug resistance gene 1 (MDR1, also called ABCB1) in breast tumors has been associated with treatment and with a poor response to chemotherapy (Trock et al., 1997). The gene discussed is TBC1D9; the disease is breast neoplasm.